Information on IMD109
Name: Immunodeficiency 109 with lymphoproliferation | Acronym: IMD109
Alt. names: CD137 deficiency | 41BB
Gene: TNFRSF9 | MOI: Autosomal recessive | Mechanism of action: Loss of Function
No. of cases in DB: 0 | First reported in: 2019
Last updated on: 2023-06-19 by Andrés Caballero-Oteyza
Description
It is characterized by onset of recurrent sinopulmonary infections in childhood. Patients are susceptible to infection with EBV and develop EBV lymphoproliferation, chronic active EBV infection or B-cell lymphoma. Immunophenotyping shows low IgG and IgA, poor responses to T cell-dependent and T-cell independent antigens, decreased T cell proliferation, IFNg secretion and cytotoxicity, with normal numbers of circulating B, NK and T cells.
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of clinical findings
[Considering only Definitive and Possible cases]
Age of onset
distribution
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).